Rocket


News + Filings
Transactions





Farzan Nima

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/06/2023Keros Therapeutics, Inc.KROSGrantStock Option (right to buy)10k$48.79$487.9k 06/06/2023
02/10/2023Kinnate Biopharma Inc. GrantEmployee Stock Option (right to buy)750k$6.78$5.1M 02/10/2023
06/01/2022Keros Therapeutics, Inc.KROSGrantStock Options (right to buy)8.3k$32.95$273.3k 06/01/2022
02/11/2022Kinnate Biopharma Inc. GrantEmployee Stock Option (right to buy)400k$10.03$4M 02/11/2022
06/01/2021Keros Therapeutics, Inc.KROSGrantStock Option (right to buy)8.3k$51.48$426.9k 06/01/2021
02/12/2021Kinnate Biopharma Inc. GrantEmployee stock option (right to buy)275k$35.38$9.7M 02/12/2021
05/29/2020Keros Therapeutics, Inc.KROSGrantStock Option (right to buy)8.5k$28.74$244.3k 05/29/2020

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy